These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 6389474

  • 1. Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits.
    McColm AA, Ryan DM, Acred P.
    J Antimicrob Chemother; 1984 Oct; 14(4):373-7. PubMed ID: 6389474
    [Abstract] [Full Text] [Related]

  • 2. Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin.
    McColm AA, Ryan DM.
    J Antimicrob Chemother; 1985 Sep; 16(3):349-58. PubMed ID: 3902761
    [Abstract] [Full Text] [Related]

  • 3. Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.
    Carrizosa J, Santoro J, Kaye D.
    Antimicrob Agents Chemother; 1978 Jan; 13(1):74-7. PubMed ID: 626493
    [Abstract] [Full Text] [Related]

  • 4. Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
    Steckelberg JM, Rouse MS, Tallan BM, Osmon DR, Henry NK, Wilson WR.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):554-8. PubMed ID: 8460924
    [Abstract] [Full Text] [Related]

  • 5. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J, Carrizosa J, Kaye D, Kobasa WD.
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [Abstract] [Full Text] [Related]

  • 6. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of cefepime in a Staphylococcus aureus endocarditis rat model.
    Lamb LM, Hibbard JR, Desiderio JV, Tsai YH.
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():95-101. PubMed ID: 8150772
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
    [Abstract] [Full Text] [Related]

  • 10. Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.
    Baker RL, Fass RJ.
    Antimicrob Agents Chemother; 1984 Aug; 26(2):231-4. PubMed ID: 6385840
    [Abstract] [Full Text] [Related]

  • 11. Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa.
    Fantin B, Farinotti R, Thabaut A, Carbon C.
    J Antimicrob Chemother; 1994 Mar; 33(3):563-9. PubMed ID: 8040120
    [Abstract] [Full Text] [Related]

  • 12. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA.
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS, Lam K.
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [Abstract] [Full Text] [Related]

  • 14. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML, de Górgolas M.
    J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
    [Abstract] [Full Text] [Related]

  • 15. Significance of methicillin tolerance in experimental staphylococcal endocarditis.
    Goldman PL, Petersdorf RG.
    Antimicrob Agents Chemother; 1979 Jun; 15(6):802-6. PubMed ID: 258111
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Dailey CF, Dileto-Fang CL, Buchanan LV, Oramas-Shirey MP, Batts DH, Ford CW, Gibson JK.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
    [Abstract] [Full Text] [Related]

  • 17. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Maserati R, Cagni AE, Segú C.
    Chemotherapy; 1996 Aug; 42(2):133-9. PubMed ID: 8697888
    [Abstract] [Full Text] [Related]

  • 18. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW, Boscia JA, Kobasa WD, Kaye D.
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [Abstract] [Full Text] [Related]

  • 19. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N, Jacqueline C, Le Mabecque V, Batard E, Bugnon D, Potel G, Caillon J.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [Abstract] [Full Text] [Related]

  • 20. Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis.
    Gengo FM, Mannion TW, Nightingale CH, Schentag JJ.
    J Antimicrob Chemother; 1984 Dec; 14(6):619-31. PubMed ID: 6520062
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.